Annual Drug Patent Expirations for AMPYRA
Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers.
Drug patent litigation for AMPYRA.
The generic ingredient in AMPYRA is dalfampridine. Two suppliers are listed for this compound. Additional details are available on the dalfampridine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
